Under the new collaboration agreement WuXi PharmaTech will synthesize compounds, according to AstraZeneca’s designs, which will further expand AstraZeneca’s global compound collection. In April 2006, WuXi PharmaTech and
Under the terms of the agreement, Genentech will make an undisclosed upfront payment to Symphogen, as well as an equity investment in Symphogen. In addition, Symphogen is eligible
KineMed’s kinetic biomarker of chronic lymphocytic leukemia flux as a predictor of disease course is intended to stratify indolent (simmering) versus aggressive disease. GeneGo’s genetic pathway database aligns
The company said that the failure to meet the two primary endpoints was the effect of AZ-002 on the incidence of a doxapram-induced panic attack and the effect
Pursuant to the agreement, Daiichi Sankyo will acquire the entire shareholding of the Singh family in Ranbaxy and further seek to acquire the majority of the voting capital
Mr French succeeds Steven Quay, who has been appointed chief scientific officer and chairman of MDRNA’s scientific advisory board and will remain chairman of the board of directors.
Under the agreement, Cellectricon will provide AstraZeneca with two of its new high throughput platforms, DynaflowHT, for ion channel screening. The DynaflowHT System will be launched and commercially
A total of 82 patients with saphenous vein incompetence were treated with Varisolve, of whom 57 patients met the study requirement of having bubbles detected in the cerebral
The Phase II study evaluated the efficacy, safety and tolerability of taspoglutide in patients with type 2 diabetes mellitus inadequately controlled with metformin. In the study, 306 patients
DioGenix plans to refine these gene sets and further confirm their disease association before it begins to develop an effective commercial assay for diagnosing patients presenting with early
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.